A complementary study demonstrated that PD-1 inhibition in a mouse model of B16F10 melanoma resulted in an increase in GLUT1 expression and subsequent increase in the uptake of glucose analogue [18F]FDG by cancer cells [36]. This evidence concerns the gene SLC2A1 and melanoma.